--- title: Buy Brilinta (Ticagrelor) 60mg/90mg Pills Online description: Brilinta (Ticagrelor) 60mg/90mg pills reduce risk of heart events after acute coronary syndrome. Order from our secure online pharmacy for verified quality. type: product language: en url: https://liabilis.com/order-brilinta-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 27.99 price_max: 306.99 currency: USD offers: - name: 60mg x 14 pills price: 27.99 - name: 60mg x 28 pills price: 49.99 - name: 60mg x 56 pills price: 86.99 - name: 60mg x 84 pills price: 118.99 - name: 60mg x 112 pills price: 133.99 - name: 60mg x 168 pills price: 167.99 - name: 90mg x 14 pills price: 63.99 - name: 90mg x 28 pills price: 81.99 - name: 90mg x 56 pills price: 140.99 - name: 90mg x 84 pills price: 191.99 - name: 90mg x 112 pills price: 230.99 - name: 90mg x 168 pills price: 306.99 --- # Buy Brilinta (Ticagrelor) 60mg/90mg Pills Online Brilinta, containing ticagrelor, is an antiplatelet medication developed by AstraZeneca. It prevents blood clots to lower risks of heart attack and stroke in ACS patients. For adults post-heart event. Our online pharmacy offers a reliable way to access Brilinta in 60mg and 90mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **60mg** | 14 pills | **$27.99** | $2.00 | In Stock | | **60mg** | 28 pills | **$49.99** | $1.79 | In Stock | | **60mg** | 56 pills | **$86.99** | $1.55 | In Stock | | **60mg** | 84 pills | **$118.99** | $1.42 | In Stock | | **60mg** | 112 pills | **$133.99** | $1.20 | In Stock | | **60mg** | 168 pills | **$167.99** | $1.00 | In Stock | | **90mg** | 14 pills | **$63.99** | $4.57 | In Stock | | **90mg** | 28 pills | **$81.99** | $2.93 | In Stock | | **90mg** | 56 pills | **$140.99** | $2.52 | In Stock | | **90mg** | 84 pills | **$191.99** | $2.29 | In Stock | | **90mg** | 112 pills | **$230.99** | $2.06 | In Stock | | **90mg** | 168 pills | **$306.99** | $1.83 | In Stock | [Buy Now](https://liabilis.com/order-brilinta-online-en.html) ## Introduction Brilinta contains the antiplatelet agent ticagrelor and is supplied as oral tablets in strengths of 60 mg and 90 mg. It belongs to the class of P2Y12 receptor antagonists, which reduce platelet aggregation and lower the risk of thrombotic cardiovascular events. Brilinta is primarily prescribed after an acute coronary syndrome (ACS) or for patients undergoing percutaneous coronary intervention (PCI). ## Quick Reference Facts **Active Ingredient** : Ticagrelor **Form** : Pill 60 mg | 90 mg **Primary and Off-Label Uses** : Acute coronary syndrome (ACS) - post-ACS management : Secondary prevention after percutaneous coronary intervention (PCI) : Reducing risk of stroke in patients with atherosclerotic disease (off-label) : Peripheral artery disease symptom relief (off-label) ## What is Brilinta? Brilinta is a branded formulation of ticagrelor, a reversible P2Y12 receptor inhibitor that prevents platelet activation. It was developed by AstraZeneca and received regulatory approval in the United States and Europe for the treatment of ACS in 2011. While Brilinta is the market-named product, generic ticagrelor tablets are also available, offering a cost-effective alternative to the brand. ## How Brilinta Works Ticagrelor binds directly and reversibly to the P2Y12 ADP receptor on platelets. By blocking this receptor, it prevents ADP-mediated platelet activation and aggregation, which are key steps in clot formation after coronary artery injury. Unlike clopidogrel, ticagrelor does not require metabolic activation, leading to a more rapid onset (within 30 minutes) and a more consistent antiplatelet effect. The drug is metabolised mainly by CYP3A4 to an active metabolite, and both parent and metabolite are eliminated through hepatic pathways and the kidneys, giving a half-life of approximately 7 hours. ## Conditions Treated with Brilinta - **Acute Coronary Syndrome (ACS)** - Brilinta reduces the composite risk of cardiovascular death, myocardial infarction, or stroke when added to aspirin, because it blocks platelet-driven thrombus formation during the vulnerable post-event period. - **Post-PCI Secondary Prevention** - After stent placement, the drug limits in-stent thrombosis by maintaining platelet inhibition throughout the healing phase, decreasing the need for repeat revascularisation. ## Is Brilinta the Right Medication for You? Brilinta is most suitable for adults who have experienced an ACS event (unstable angina, NSTEMI, or STEMI) or who have undergone PCI with stent implantation. It is especially beneficial for patients who require rapid and reliable platelet inhibition and who have no history of active bleeding. Contraindications include: current pathological bleeding, prior intracranial haemorrhage, severe hepatic impairment, and concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole). Patients with a high risk of bradyarrhythmia or severe asthma should be evaluated carefully before initiation. ## Buying Brilinta from [our online pharmacy](https://liabilis.com/order-brilinta-online-en.html) ### Why Choose Our Service? Accessing Brilinta can be challenging due to cost or limited local supply. Our platform connects you with verified sources, making the medication more affordable and easier to obtain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. ### Pricing & Access Because we source the generic ticagrelor equivalent, prices are close to wholesale rates, providing a clear cost advantage over brand-only options. ### Discreet Delivery Orders are packaged in neutral, unmarked parcels and shipped with express delivery typically within 7 days or standard airmail in approximately 3 weeks, protecting your privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose **Standard Dosing** - Loading dose: 180 mg (three 60 mg tablets) taken once, followed by maintenance. - Maintenance: 60 mg twice daily, or 90 mg twice daily in patients with high thrombotic risk where physician deems a higher dose appropriate. **Missed Dose** - If a dose is missed and the next scheduled dose is more than 8 hours away, take the missed dose. - If the next dose is within 8 hours, skip the missed dose and resume the regular schedule. Do not double-dose. **Overdose** - Symptoms may include severe bleeding, dizziness, or fainting. Seek emergency medical attention immediately. - Contact a poison-control centre and inform them of the amount ingested. **Practical Precautions** - Take tablets with or without food; avoid crushing. - Alcohol can increase bleeding risk; limit consumption. - Do not operate heavy machinery until you know how Brilinta affects you, as dizziness may occur. ## Safety Information ### ⚠️ Who Should Not Take Brilinta - Active pathological bleeding (e.g., gastrointestinal ulcer bleeding) - History of intracranial haemorrhage or recent stroke with haemorrhagic component - Severe hepatic impairment (Child-Pugh C) - Concomitant use of strong CYP3A4 inhibitors (ketoconazole, clarithromycin, etc.) ### Common Side Effects - Dyspnea (shortness of breath) - occurs in up to 15 % of patients; usually mild and transient. - Minor bruising or bleeding from gums and nose - typically self-limiting. - Headache and dizziness - often resolve within the first few weeks of therapy. ### Serious Side Effects (Seek Immediate Medical Help) - Severe or uncontrolled bleeding (e.g., haematemesis, melena, intracranial bleed) - Allergic reactions such as rash, angioedema, or anaphylaxis - Sudden, unexplained drop in blood pressure or fainting spells ### Drug & Food Interactions - **CYP3A4 inhibitors** (ketoconazole, ritonavir) - increase ticagrelor plasma levels, raising bleeding risk. - **CYP3A4 inducers** (rifampin, carbamazepine) - reduce efficacy, potentially leading to clot formation. - **Aspirin** - combined use is standard for dual antiplatelet therapy; however, high-dose aspirin (>100 mg) may increase bleeding. - **Statins metabolised by CYP3A4** (atorvastatin, simvastatin) - monitor for myopathy; dose adjustments may be required. ## Off-Label and Investigational Uses of Brilinta - **Peripheral Artery Disease (PAD)** - Some clinical trials suggest ticagrelor may improve walking distance and reduce limb ischemic events, though regulatory approval for PAD is not established. - **Stroke Prevention in Atherosclerotic Disease** - Observational studies have explored ticagrelor as an alternative to clopidogrel for secondary stroke prevention, but formal approval is lacking. - **Acute Ischemic Stroke Thrombolysis Adjunct** - Small pilot studies evaluated ticagrelor combined with thrombolytic therapy to enhance reperfusion; results remain preliminary. All off-label applications should only be pursued under direct supervision of a qualified healthcare professional. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from light. - Do not refrigerate or freeze. - Keep out of reach of children; discard any tablets that are discoloured or past the expiry date printed on the packaging. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Brilinta?** Yes, but keep the medication in its original packaging with a copy of the prescription. Carry it in your hand luggage to avoid temperature extremes. - **Will drinking coffee affect Brilinta’s effectiveness?** Moderate coffee consumption does not significantly influence ticagrelor levels. Excessive caffeine may increase heart rate, but no direct interaction has been documented. - **Is it safe to exercise while taking Brilinta?** Regular aerobic activity is encouraged after ACS recovery. Monitor for unusual bruising or prolonged bleeding from minor injuries, and discuss any concerns with your clinician. **Product & Formulation Details** - **What do Brilinta tablets look like?** Brilinta tablets are round, film-coated, and white for the 60 mg strength; the 90 mg tablets are larger and marked with a “90” imprint. - **Can the tablets be split?** Brilinta tablets are not scored, and splitting may compromise dose uniformity. Use whole tablets as prescribed. - **Are there any inactive ingredients that could cause allergies?** Inactive components include lactose, microcrystalline cellulose, and magnesium stearate. Patients with severe lactose intolerance should consult their pharmacist. **Regulatory & Safety Nuances** - **Does Brilinta show up on standard drug tests?** Routine employment drug screens do not target ticagrelor, so it is unlikely to be detected. - **Is Brilinta safe for elderly patients?** Age alone is not a contraindication, but older adults have higher bleeding risk; dose adjustments and close monitoring are advisable. - **Can I use Brilinta while pregnant or breastfeeding?** Safety has not been established; it is classified as Category C. Use only if the potential benefit justifies the potential risk and after discussion with a obstetric specialist. **Scientific & Clinical Curiosity** - **What major trial established Brilinta’s benefit?** The PLATO (Platelet Inhibition and Patient Outcomes) trial demonstrated a significant reduction in cardiovascular death, myocardial infarction, and stroke compared with clopidogrel. - **How does Brilinta differ from clopidogrel at the molecular level?** Ticagrelor binds reversibly to the P2Y12 receptor without requiring metabolic activation, whereas clopidogrel is a pro-drug that irreversibly binds after hepatic conversion. ## Glossary **P2Y12 Receptor** : A platelet surface protein that mediates ADP-induced platelet activation; inhibition reduces clot formation. **Reversible Antagonist** : A drug that temporarily blocks a receptor and can dissociate, allowing normal function to resume after the drug is cleared. **Dual Antiplatelet Therapy (DAPT)** : The combined use of aspirin and a P2Y12 inhibitor (such as ticagrelor) to prevent arterial thrombosis. **CYP3A4** : A liver enzyme responsible for metabolising many medications, including ticagrelor; inhibitors or inducers can alter drug levels. ## Disclaimer The information provided about **Brilinta** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-brilinta-online-en.html) offers access to **Brilinta** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.